| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 10/11/2001 | WO2000029549A3 Low oxygen culturing of cells |
| 10/11/2001 | US20010029270 Aqueous solution |
| 10/11/2001 | US20010029251 Administering cytomegalo virus protein |
| 10/11/2001 | US20010029249 Adenovirus comprising a gene coding for glutathione peroxidase |
| 10/11/2001 | US20010029045 Lineage restricted glial precursors from the central nervous system |
| 10/11/2001 | US20010028882 Anti-cryptosporidium parvum preparations |
| 10/11/2001 | US20010028879 Inhibition of graft versus host disease |
| 10/11/2001 | EP1145001A3 (in vitro) model for gastrointestinal inflammation |
| 10/11/2001 | EP1144591A3 Low oxygen culturing of cells |
| 10/11/2001 | DE19964162A1 Verfahren zur Abtötung, Abschwächung und Veränderung von Bakterien, Bakteriophagen, Viren, Virophagen, Prionen und Pilzen mit hohen Drücken Method of killing, mitigation and change of bacteria, bacteriophages, viruses, Virophage, prions and fungi with high pressures |
| 10/11/2001 | DE10013223A1 In vitro preparation of cartilage and bone tissue, useful for transplantation and for pharmaceutical testing, comprises culturing cells on hydrophobic surfaces to form aggregates |
| 10/11/2001 | CA2413211A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 10/11/2001 | CA2405299A1 Method of treatment using ligand-immunogen conjugates |
| 10/11/2001 | CA2404484A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 10/11/2001 | CA2404300A1 Medical devices suitable for gene therapy regimens |
| 10/11/2001 | CA2403998A1 Mucin-1 specific binding members and methods of use thereof |
| 10/11/2001 | CA2403964A1 Compositions and methods for dendritic cell-based immunotherapy |
| 10/11/2001 | CA2401948A1 Cd20/ige-receptor like molecules and uses thereof |
| 10/11/2001 | CA2399399A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
| 10/10/2001 | EP1143004A2 Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from bacillus thuringiensis isolates |
| 10/10/2001 | EP1142989A2 Chondrocyte cell-lines |
| 10/10/2001 | EP1142987A1 Composition of powdered aureobacidium culture solution, manufacturing method thereof and powder mixture with the composition |
| 10/10/2001 | EP1142905A1 Novel depsipeptide compound |
| 10/10/2001 | EP1142904A1 Sponge protein hydrolysates and methods of producing the same |
| 10/10/2001 | EP1142578A1 Method for producing an antitumoral agent and antitumoral agent thus obtained |
| 10/10/2001 | EP1142473A1 Method of acquiring immunological tolerance |
| 10/10/2001 | EP1141720A1 Detection of preactivated phagocytes |
| 10/10/2001 | EP1141357A1 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 10/10/2001 | EP1141343A1 Non-viral transfection vector |
| 10/10/2001 | EP1141342A2 Use of plus-strand synthesis elements in retroviral vectors |
| 10/10/2001 | EP1141340A1 A method for introducing substances into cells, and use of said method |
| 10/10/2001 | EP1141339A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 10/10/2001 | EP1141338A1 Recombinant herpes simplex virus useful for treating neoplastic disease |
| 10/10/2001 | EP1141318A2 P450 / acetaminophen gdept for cancer treatment |
| 10/10/2001 | EP1141314A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 10/10/2001 | EP1141311A1 Protective antigen of group a streptococci (spa) |
| 10/10/2001 | EP1141296A2 Interferon-epsilon |
| 10/10/2001 | EP1141290A2 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 10/10/2001 | EP1141280A1 Minor histocompatibility antigens and their use in the diagnosis and treatment of tumors |
| 10/10/2001 | EP1141266A2 Expression vectors comprising multiple shear stress responsive elements (ssre) and a gene of interest and methods of use thereof |
| 10/10/2001 | EP1141246A2 Non-myeloablative tolerogenic treatment |
| 10/10/2001 | EP1141245A1 Somatic cells with ablated prp gene and methods of use |
| 10/10/2001 | EP1141243A2 Methods of immunosuppression |
| 10/10/2001 | EP1141241A2 Astrocytes, their preparation and uses thereof |
| 10/10/2001 | EP1141240A1 Use of cd40 engagement to alter t cell receptor usage |
| 10/10/2001 | EP1141235A2 (bifidobacterium) in the treatment of inflammatory disease |
| 10/10/2001 | EP1141021A1 Removal/purification of serum albumins |
| 10/10/2001 | EP1141017A2 Characterization of the soc/crac calcium channel protein family |
| 10/10/2001 | EP1141013A2 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS |
| 10/10/2001 | EP1141007A1 Compositions and methods for enhancement of major histocompatibility complex class i restricted antigen presentation |
| 10/10/2001 | EP1140995A2 Peptides for inhibiting hbv core proteins |
| 10/10/2001 | EP1140989A1 Alpha(v) beta(6) integrin inhibitors |
| 10/10/2001 | EP1140987A1 Peptides for inhibiting hpv e6 proteins |
| 10/10/2001 | EP1140978A1 Methods of identifying antigen gene sequences |
| 10/10/2001 | EP1140967A1 Targeted gene transfer using g protein coupled receptors |
| 10/10/2001 | EP1140885A1 Method for high yield extraction of paclitaxel from paclitaxel-containing material |
| 10/10/2001 | EP1140291A1 Combination chemotherapy comprising a mitotic inhibitor and a mek inhibitor |
| 10/10/2001 | EP1140290A2 Synergistic tumorcidal response induced by histamine |
| 10/10/2001 | EP1140240A1 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 10/10/2001 | EP1140214A1 Removal of biological contaminants |
| 10/10/2001 | EP1140208A1 Pharmaceutical compositions comprising immortalised endothelial cells |
| 10/10/2001 | EP1140207A1 Mammalian cell preparations optionally transfected with a gene coding for an active substance containing same |
| 10/10/2001 | EP1140205A2 GENE THERAPY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING Na,K-ATPase |
| 10/10/2001 | EP1140164A2 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation |
| 10/10/2001 | EP1140149A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 10/10/2001 | EP1140140A2 Composition and method for improving function of embryonic kidney transplants |
| 10/10/2001 | EP1140138A2 Therapeutic applications of flint polypeptides |
| 10/10/2001 | EP1140122A1 Pro-apoptotic agents |
| 10/10/2001 | EP1140120A2 Human brainiac-5 |
| 10/10/2001 | EP1140040A1 Spray-type cosmetic composition and matrix used in said composition for dermal administration |
| 10/10/2001 | EP1140010A2 Substrate composition and method of use for sequestration of skin irritants |
| 10/10/2001 | EP1140009A2 Absorbent article composition and method of use for sequestering skin irritants |
| 10/10/2001 | EP1139784A1 Food-induced antisecretory proteins in egg yolk |
| 10/10/2001 | EP1139751A1 Efficient and stable $i(in vivo) gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors |
| 10/10/2001 | EP1139750A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues |
| 10/10/2001 | EP1033993B1 Use of the e.coli strain dsm 6601 for treating diarrhoea in veterinary medicine |
| 10/10/2001 | CN1317045A Pharmaceutical uses of NAB1 and NAB2 |
| 10/10/2001 | CN1316906A Stable liquid formulations of botulinum toxin |
| 10/10/2001 | CN1316905A Composition for stimulation melanin synthetic and preparing method thereof |
| 10/10/2001 | CN1316268A Qufengbaidu pill for treating skin itchings |
| 10/10/2001 | CN1316260A Medicine for treating impotence |
| 10/10/2001 | CN1316252A Exterior-applied medicine for treating acne and its preparing process |
| 10/10/2001 | CN1316251A Capsule for treating nasosimusitis |
| 10/10/2001 | CN1316249A Nutritive active liquid of scorpion |
| 10/10/2001 | CN1316196A Nutritive health-care food for conditioning male sexual function |
| 10/10/2001 | CN1072503C Medicine for treating angitis |
| 10/10/2001 | CN1072502C Medicine for treating angitis |
| 10/10/2001 | CN1072501C Pile-diminishing capsule |
| 10/10/2001 | CN1072499C External-use medicine for curing body surface chronic ulcers |
| 10/10/2001 | CN1072498C External-use medicine for treating burn and scald of humanbody |
| 10/10/2001 | CN1072497C Medicine for curing hemiplegia and its making method |
| 10/10/2001 | CN1072496C Haisong injury paste |
| 10/10/2001 | CN1072495C Health-care mattress with functions dispelling wind and clearing away cold, removing dampness and warming kidney |
| 10/10/2001 | CN1072493C Compound asthma capsule and its preparation method |
| 10/10/2001 | CN1072491C Nutritive liquid for nourishing brain and promoting intelligence growth |
| 10/10/2001 | CN1072487C Dispensing of soft-shelled turtle tonic wine and its preparation method |
| 10/10/2001 | CN1072461C Wild jujube health-care drink and preparetion method thereof |
| 10/09/2001 | US6300490 Expression vector coding cytosine deaminase; for use in the treatment of cancers |
| 10/09/2001 | US6300355 For therapy of cancer |
| 10/09/2001 | US6300314 Admnistering heterocyclic peptides to stimulate hematopoiesis of cells |